Abstract
Levels of residual structure in disordered interaction domains determine in vitro binding affinities, but whether they exert similar roles in cells is not known. Here, we show that increasing residual p53 helicity results in stronger Mdm2 binding, altered p53 dynamics, impaired target gene expression and failure to induce cell cycle arrest upon DNA damage. These results establish that residual structure is an important determinant of signaling fidelity in cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wright, P.E. & Dyson, H.J. Curr. Opin. Struct. Biol. 19, 31–38 (2009).
Marsh, J.A., Teichmann, S.A. & Forman-Kay, J.D. Curr. Opin. Struct. Biol. 22, 643–650 (2012).
Frederick, K.K., Marlow, M.S., Valentine, K.G. & Wand, A.J. Nature 448, 325–329 (2007).
Drobnak, I. et al. J. Am. Chem. Soc. 135, 1288–1294 (2013).
Iešmantavičius, V., Dogan, J., Jemth, P., Teilum, K. & Kjaergaard, M. Angew. Chem. Int. Edn Engl. 53, 1548–1551 (2014).
Vousden, K.H. & Lane, D.P. Nat. Rev. Mol. Cell Biol. 8, 275–283 (2007).
Wu, X., Bayle, J.H., Olson, D. & Levine, A.J. Genes Dev. 7, 1126–1132 (1993).
Kruse, J.P. & Gu, W. Cell 137, 609–622 (2009).
Vousden, K.H. & Prives, C. Cell 137, 413–431 (2009).
Lahav, G. et al. Nat. Genet. 36, 147–150 (2004).
Lee, H. et al. J. Biol. Chem. 275, 29426–29432 (2000).
Vise, P.D., Baral, B., Latos, A.J. & Daughdrill, G.W. Nucleic Acids Res. 33, 2061–2077 (2005).
Wells, M. et al. Proc. Natl. Acad. Sci. USA 105, 5762–5767 (2008).
Kussie, P.H. et al. Science 274, 948–953 (1996).
Li, C. et al. J. Mol. Biol. 398, 200–213 (2010).
Mittal, J., Yoo, T.H., Georgiou, G. & Truskett, T.M. J. Phys. Chem. B 117, 118–124 (2013).
Zondlo, S.C., Lee, A.E. & Zondlo, N.J. Biochemistry 45, 11945–11957 (2006).
Batchelor, E., Mock, C.S., Bhan, I., Loewer, A. & Lahav, G. Mol. Cell 30, 277–289 (2008).
Vassilev, L.T. et al. Science 303, 844–848 (2004).
Maki, C.G., Huibregtse, J.M. & Howley, P.M. Cancer Res. 56, 2649–2654 (1996).
El-Deiry, W.S. et al. Cell 75, 817–825 (1993).
Miyashita, T. & Reed, J.C. Cell 80, 293–299 (1995).
Purvis, J.E. et al. Science 336, 1440–1444 (2012).
Sablina, A.A. et al. Nat. Med. 11, 1306–1313 (2005).
Toettcher, J.E. et al. Proc. Natl. Acad. Sci. USA 106, 785–790 (2009).
Johnson, B.A.R. & Blevins, R.A. J. Biomol. NMR 4, 603–614 (1994).
Tamiola, K., Acar, B. & Mulder, F.A. J. Am. Chem. Soc. 132, 18000–18003 (2010).
Schwarzinger, S. et al. J. Am. Chem. Soc. 123, 2970–2978 (2001).
Theillet, F.X. et al. Nat. Protoc. 8, 1416–1432 (2013).
Brummelkamp, T.R., Bernards, R. & Agami, R. Science 296, 550–553 (2002).
Dull, T. et al. J. Virol. 72, 8463–8471 (1998).
Gaglia, G., Guan, Y., Shah, J.V. & Lahav, G. Proc. Natl. Acad. Sci. USA 110, 15497–15501 (2013).
Loewer, A., Batchelor, E., Gaglia, G. & Lahav, G. Cell 142, 89–100 (2010).
Menendez, D. et al. Nucleic Acids Res. 41, 7286–7301 (2013).
Nikulenkov, F. et al. Cell Death Differ. 19, 1992–2002 (2012).
Acknowledgements
We thank P. Schmieder and M. Beerbaum for excellent NMR infrastructure maintenance (FMP Berlin) and W. Chen for Illumina sequencing (Max Delbrueck Center). This research was supported by the Deutsche Forschungsgemeinschaft (Emmy Noether grant PS1794/1-1 to P.S.), the Association pour la Recherche contre le Cancer (postdoctoral fellowship to F.-X.T.), the European Union FP7 (Marie Curie CIG to A.L.), the American Cancer Society (RSG-07-289-01-GMC to G.W.D.) and the National Science Foundation (MCB-0939014 to G.W.D.). Protein NMR resources at the University of South Florida were provided by the Center for Drug Discovery and Innovation.
Author information
Authors and Affiliations
Contributions
W.B., F.-X.T. and H.W. collected and analyzed NMR data. W.B., K.M.M. and A.T.P. prepared p53TAD and Mdm2 protein samples, F.-X.T., K.M.M. and A.T.P. collected and analyzed ITC data. W.M. provided the protocol for Mdm2 expression and purification. F.-X.T. and A.K. generated and analyzed mutant p53 cell lines, A.F. performed RNA-seq experiments, and C.D. provided bioinformatics analysis. F.-X.T. and W.B. assisted in the writing of the manuscript. P.S., A.L. and G.W.D. conceived the study, supervised the research, analyzed the data, prepared the figures and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Results and Supplementary Figures 1–10. (PDF 19769 kb)
Rights and permissions
About this article
Cite this article
Borcherds, W., Theillet, FX., Katzer, A. et al. Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells. Nat Chem Biol 10, 1000–1002 (2014). https://doi.org/10.1038/nchembio.1668
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1668
This article is cited by
-
Structural biases in disordered proteins are prevalent in the cell
Nature Structural & Molecular Biology (2024)
-
p53 and p21 dynamics encode single-cell DNA damage levels, fine-tuning proliferation and shaping population heterogeneity
Communications Biology (2023)
-
Evolutionary fine-tuning of residual helix structure in disordered proteins manifests in complex structure and lifetime
Communications Biology (2023)
-
Rational design of a helical peptide inhibitor targeting c-Myb–KIX interaction
Scientific Reports (2022)
-
EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction
Nature Communications (2021)